Efficacy of pharmacological treatments for Dravet syndrome: Systematic review and network …
✦ New CED Clinical Relevance #85 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchNeurologyCBDPediatricsSafety Why This Matters This systematic review and network meta-analysis provides…
CBD in Childhood Epilepsy: What the Evidence Actually Shows
Several randomized controlled trials demonstrate cannabidiol pediatric epilepsy dosing reduces seizures in syndromes like Lennox-Gastaut and Dravet. This review summarizes dosing, drug interactions, and safety monitoring for cannabidiol in pediatric…
What the Evidence Really Says About CBD for Children With Epilepsy
This 2025 review highlights CBD pediatric epilepsy drug interactions and their impact on seizure management in children. Pharmaceutical-grade CBD shows meaningful seizure reduction in drug-resistant epilepsy. Careful monitoring and dosing are essential…
CBD for Childhood Epilepsy: What the Evidence Actually Shows
A 2025 clinical update highlights cannabidiol pediatric epilepsy evidence showing meaningful seizure reduction in children with drug-resistant epilepsy. The review emphasizes dosing protocols and safety monitoring. Cannabidiol pediatric epilepsy…
Implementation of a Standardized Management Algorithm for Cannabis Hyperemesis Syndrome in a Pediatric Emergency Department.
Cannabis hyperemesis syndrome (CHS) is an increasingly common cause of pediatric emergency department (ED) visits, yet management pathways remain understudie...
Fear of recurrence, secondary cancers, and health problems in long-term survivors of childhood cancer: Findings from a Canadian cohort.
Survivors of childhood cancer are at lifelong risk for health problems, secondary cancers, and recurrence. However, little is known about their fears related...
Legal Penalties for Selling Hemp-Derived Cannabinoids to Minors in Tennessee
Tennessee hemp-derived cannabinoid penalties now include mandatory jail time and fines for selling to minors. This law aims to protect youth from unregulated psychoactive hemp products. Clinicians should understand these penalties to counsel patients and…
Cannabis, Psychedelics, and the Profit Motive Blocking Psychiatric Drugs
The 2026 cannabis psychedelic research update reveals emerging clinical insights into psychiatric drug development. This update highlights barriers created by profit motives that delay patient access. Clinicians must stay informed about these…
Endocannabinoid System in Autism Development Research
Maternal cannabis exposure autism risk is linked to behavioral problems and developmental delays in children. Research shows stronger associations in children with autism spectrum disorder symptoms. Understanding these risks is crucial for clinical…
Insights from the CBD Autism Anxiety Clinical Trial Study
This clinical study on cbd autism anxiety trial results reveals measurable improvements in social interaction and anxiety symptoms in autistic children. The trial used a randomized controlled design to assess CBD oil effects. Findings suggest potential…
